Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2010
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874816A Tripterygium hypoglaucum film coated tablets and preparation method thereof
11/03/2010CN101874809A Local anti-inflammatory external medicinal composition using glycerol DMSO mixed solvent
11/03/2010CN101874798A Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
11/03/2010CN101874797A Application of perillene in preparation of anti-inflammatory medicaments
11/03/2010CN101874794A Ibuprofen and lysine medicament compound as well as preparation method and application thereof
11/03/2010CN101874792A Phloroglucinol orally disintegrating tablets and preparation method thereof
11/03/2010CN101874533A Golden bamboo tea
11/03/2010CN101342290B Tong bi liquid and preparation method thereof
11/03/2010CN101342279B Liquid for expelling wind, dissipating cold and relaxing vein, and preparation method thereof
11/03/2010CN101314016B Compound andrographis paniculata injection for treating pig hyperpyrexia and preparation method thereof
11/03/2010CN101297826B Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/03/2010CN101279964B Guaiane type sesquiterpenes, preparation and medical use thereof
11/03/2010CN101264242B Medicaments preparations for treating hemorrhage, pain and dropsy
11/03/2010CN101252923B Adhesive skin patch
11/03/2010CN101235039B Chemical total synthesis method for wedelolactone
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825236 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825157 Methods for improving the aesthetic appearance of skin
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7825124 Indolylmaleimide derivatives
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010CA2470391C N,n'-disubstituted piperazine compounds and their use as analgesics
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2460144C Pyridinic sulfonamide derivatives, method of production and use thereof
11/02/2010CA2458740C Method of treating systemic inflammatory response syndrome
11/02/2010CA2446639C Composition for the prevention of addiction in pain management
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2436361C Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2416771C 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
11/02/2010CA2383293C Anti-infective compositions for treating disordered tissue such as cold sores
11/02/2010CA2336602C Companion animal therapeutic treat
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010WO2010124122A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124121A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
10/28/2010WO2010124119A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124116A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124114A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124112A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124102A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124086A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124082A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010123832A2 2-oxamide inhibitors of phospholipase a2 activity and cellular arachidonate release based on dipeptides and pseudopeptides
10/28/2010WO2010123507A1 Treatment of non-localized inflammation with pan-hdac inhibitors
10/28/2010WO2010123069A1 Method for diagnosing autoimmune disease patient, in vitro diagnostic agent and therapeutic agent therefor
10/28/2010WO2010122344A1 Novel use
10/28/2010WO2010122343A1 A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
10/28/2010WO2010122294A1 Thiophene inhibitors of ikk-b serine-threonine protein kinase
10/28/2010WO2010122069A1 5-alkynyl-pyridines
10/28/2010WO2010122038A1 Inhibitors of bruton's tyrosine kinase
10/28/2010WO2010121762A1 Paracetamol for parenteral administration
10/28/2010WO2010121325A1 A novel formulation of meloxicam
10/28/2010WO2010075287A3 Compounds and methods for the treatment of pain and other diseases
10/28/2010WO2009142732A3 Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
10/28/2010WO2009114814A3 Therapeutic substances that modulate genome methylation
10/28/2010US20100273895 Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the same
10/28/2010US20100273893 Protective effect of thymoquinone in spesis
10/28/2010US20100273891 Isoflavone metabolites
10/28/2010US20100273881 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
10/28/2010US20100273872 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273853 Novel isoindol derivatives as ep4 receptor agonists
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273816 Quinazoline Compounds
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273805 Sulphide bridged derivatives as modulators of mglur5 733
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273777 Compounds for Modulating TRPV3 Function
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273773 Dibenzoazepine and dibenzooxazepine trpa1 agonists
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/28/2010US20100273768 Inhibitors of Bruton's Tyrosine Kinase
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273761 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273754 Organic compounds
10/28/2010US20100273752 Mequitazine for treating or preventing pathologies involving histamine h4 receptors
10/28/2010US20100273750 Serotonin receptor antagonists for treating arthritis
10/28/2010US20100273746 Pharmaceutical formulations containing tolperisone
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273716 New uses for amino acid anticonvulsants
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 1272